By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

EyeGate Pharma 

100 Beaver Street

Waltham  Massachusetts  02453-8425  U.S.A.
Phone: 781-788-8869 Fax:


SEARCH JOBS


Industry
Medical Device






Company News
EyeGate Pharma Enrolls First Patient In Confirmatory Phase 3 Clinical Trial EGP-437-006 For Non-infectious Anterior Uveitis 1/21/2016 10:00:08 AM
EyeGate Pharma Reports Third Quarter 2015 Financial Results And Provides Business Update 11/12/2015 7:19:21 AM
EyeGate Pharma Announces Interim Data From Phase Ib/IIa Clinical Trial Of Iontophoretic EGP-437 Ophthalmic Solution In Macular Edema Patients 11/5/2015 7:56:06 AM
EyeGate Pharma Receives USPTO Notice Of Allowance For Next Generation Of Proprietary Iontophoretic Delivery System 10/15/2015 7:45:49 AM
EyeGate Pharma To Present At The 17th Rodman & Renshaw 2015 Annual Global Investment Conference 9/1/2015 12:35:28 PM
EyeGate Pharma Announces Closing Of Public Offering Of Common Stock And Warrants 8/5/2015 1:25:31 PM
EyeGate Pharma Announces Pricing Of $10,000,000 Public Offering Of Common Stock And Warrants 7/31/2015 7:09:38 AM
EyeGate Pharma Receives USPTO Notice Of Allowance For Proprietary Dexamethasone Phosphate Formulation 7/24/2015 7:17:18 AM
EyeGate Pharma Treats First Patient In Phase Ib / 2a Trial Of EGP-437 In Macular Edema 7/14/2015 7:17:29 AM
EyeGate Pharma Signs Licensing Agreement With Valeant (VRX) For EGP-437 Combination Product In Uveitis 7/10/2015 6:59:38 AM
12345
//-->